Iron and mechanisms of neurotoxicity

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Salvador, Gabriela A ^a   Uranga, Romina M ^a   Giusto, Norma M ^a  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; IRON;

BRAIN LEVEL; DEGENERATIVE DISEASE; MOLECULAR INTERACTION; NEUROTOXICITY; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 79952142387     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/720658     Document Type: Review

References (120)

1. Mills E., Dong X. P., Wang F., Xu H., Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders Future Medicinal Chemistry 2010 2 1 51 64
2. Connor J. R., Benkovic S. A., Iron regulation in the brain: histochemical, biochemical, and molecular considerations Annals of Neurology 1992 32 S51 S61
3. Liu G., Huang W., Moir R. D., Vanderburg C. R., Lai B., Peng Z., Tanzi R. E., Rogers J. T., Huang X., Metal exposure and Alzheimer's pat (Pubitemid 43884894)
4. Rouault T. A., Systemic iron metabolism: a review and implications for brain iron metabolism Pediatric Neurology 2001 25 2 130 137 (Pubitemid 32830162)
5. Youdim M. B. H., Fridkin M., Zheng H., Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases Mechanisms of Ageing and Development 2005 126 2 317 326 (Pubitemid 40038353)
6. Kell D. B., Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples Archives of Toxicology 2010 84 11 825 889
7. Barnham K. J., Bush A. I., Metals in Alzheimer's and Parkinson's Diseases Current Opinion in Chemical Biology 2008 12 2 222 228
8. Bica L., Crouch P. J., Cappai R., White A. R., Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer's disease Molecular BioSystems 2009 5 2 134 142
9. Christen Y., Oxidative stress and Alzheimer disease American Journal of Clinical Nutrition 2000 71 2 621S 629S (Pubitemid 30061247)
10. Perry G., Sayre L. M., Atwood C. S., Castellani R. J., Cash A. D., Rottkamp C. A., Smith M. A., The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications CNS Drugs 2002 16 5 339 352 (Pubitemid 34548201)
11. Zatta P., Lucchini R., Van Rensburg S. J., Taylor A., The role of metals in neurodegenerative processes: aluminum, manganese, and zinc Brain Research Bulletin 2003 62 1 15 28 (Pubitemid 37330111)
12. Cho H. -H., Cahill C. M., Vanderburg C. R., Scherzer C. R., Wang B., Huang X., Rogers J. T., Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1 Journal of Biological Chemistry 2010 285 41 31217 31232
13. Frackowiak J., Potempska A., Mazur-Kolecka B., Formation of amyloid- oligomers in brain vascular smooth muscle cells transiently exposed to iron-induced oxidative stress Acta Neuropathologica 2009 117 5 557 567
14. Richardson D. R., Ponka P., The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells Biochimica et Biophysica Acta 1997 1331 1 1 40 (Pubitemid 27168147)
15. Halliwell B., The wanderings of a free radical Free Radical Biology and Medicine 2009 46 5 531 542
16. Halliwell B., Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment Drugs and Aging 2001 18 9 685 716 (Pubitemid 32948277)
17. Ke Y. A., Qian Z. M., Brain iron metabolism: neurobiology and neurochemistry Progress in Neurobiology 2007 83 3 149 173 (Pubitemid 47484044)
18. Zecca L., Youdim M. B. H., Riederer P., Connor J. R., Crichton R. R., Iron, brain ageing and neurodegenerative disorders Nature Reviews Neuroscience 2004 5 11 863 873 (Pubitemid 39482155)
19. Suh Y. J., David S., Age-related changes in iron homeostasis and cell death in the cerebellum of ceruloplasmin-deficient mice Journal of Neuroscience 2006 26 38 9810 9819 (Pubitemid 44427720)
20. Texel S. J., Xu X., Harris Z. L., Ceruloplasmin in neurodegenerative diseases Biochemical Society Transactions 2008 36, part 6 1277 1281
21. Alekseenko A. V., Waseem T. V., Fedorovich S. V., Ferritin, a protein containing iron nanoparticles, induces reactive oxygen species formation and inhibits glutamate uptake in rat brain synaptosomes Brain Research 2008 1241 193 200
22. Chinnery P. F., Crompton D. E., Birchall D., Jackson M. J., Coulthard A., Lombs A., Quinn N., Wills A., Fletcher N., Mottershead J. P., Cooper P., Kellett M., Bates D., Burn J., Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation Brain 2007 130 1 110 119 (Pubitemid 46026227)
23. Gakh O., Bedekovics T., Duncan S. F., Smith D. Y., Berkholz D. S., Isaya G., Normal and Friedreich ataxia cells express different isoforms of frataxin with complementary roles in iron-sulfur cluster assembly. Journal of Biological Chemistry. In press
24. Mantovan M. C., Martinuzzi A., Squarzanti F., Bolla A., Silvestri I., Liessi G., Macchi C., Ruzza G., Trevisan C. P., Angelini C., Exploring mental status in Friedreich's ataxia: a combined neuropsychological, behavioral and neuroimaging study European Journal of Neurology 2006 13 8 827 835 (Pubitemid 44124678)
25. Berg D., Youdim M. B., Role of iron in neurodegenerative disorders Topics in Magnetic Resonance Imaging 2006 17 1 5 17 (Pubitemid 46672929)
26. Dexter D. T., Jenner P., Schapira A. H.V., Marsden C. D., Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group Annals of Neurology 1992 32 supplement S94 S100
27. Simmons D. A., Casale M., Alcon B., Pham N., Narayan N., Lynch G., Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's Disease GLIA 2007 55 10 1074 1084 (Pubitemid 47066747)
28. Ong W. Y., Farooqui A. A., Iron, neuroinflammation, and Alzheimer's disease Journal of Alzheimer's Disease 2005 8 2 183 200 (Pubitemid 43227164)
29. Quintana C., Bellefqih S., Laval J. Y., Guerquin-Kern J. L., Wu T. D., Avila J., Ferrer I., Arranz R., Patio C., Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level Journal of Structural Biology 2006 153 1 42 54 (Pubitemid 43038614)
30. Rouault T. A., Iron on the brain Nature Genetics 2001 28 4 299 300 (Pubitemid 32702411)
31. Roy C. N., Andrews N. C., Recent advances in disorders of iron metabolism: mutations, mechanisms and modifiers Human Molecular Genetics 2001 10 20 2181 2186 (Pubitemid 32998830)
32. Imon Y., Yamaguchi S., Yamamura Y., Tsuji S., Kajima T., Ito K., Nakamura S., Low intensity areas observed on T2-weighted magnetic resonance imaging of the cerebral cortex in various neurological diseases Journal of the Neurological Sciences 1995 134 supplement 1 27 32
33. Burn J., Chinnery P. F., Neuroferritinopathy Seminars in Pediatric Neurology 2006 13 3 176 181 (Pubitemid 44709654)
34. Kasarskis E. J., Tandon L., Lovell M. A., Ehmann W. D., Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary study Journal of the Neurological Sciences 1995 130 2 203 208
35. Oba H., Araki T., Ohtomo K., Monzawa S., Uchiyama G., Koizumi K., Nogata Y., Kachi K., Shiozawa Z., Kobayashi M., Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging Radiology 1993 189 3 843 846 (Pubitemid 23354505)
36. Gregory A., Hayflick S. J., Neurodegeneration with brain iron accumulation Folia Neuropathologica 2005 43 4 286 296 (Pubitemid 43109287)
37. Levi S., Cozzi A., Arosio P., Neuroferritinopathy: a neurodegenerative disorder associated with L-ferritin mutation Best Practice and Research: Clinical Haematology 2005 18 2 265 276 (Pubitemid 40298369)
38. Curtis A. R. J., Fey C., Morris C. M., Bindoff L. A., Ince P. G., Chinnery P. F., Coulthard A., Jackson M. J., Jackson A. P., McHale D. P., Hay D., Barker W. A., Markham A. F., Bates D., Curtis A., Burn J., Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease Nature Genetics 2001 28 4 350 354 (Pubitemid 32702424)
39. Levine S. M., Iron deposits in multiple sclerosis and Alzheimer's disease brains Brain Research 1997 760 1-2 298 303 (Pubitemid 27304170)
40. LeVine S. M., Chakrabarty A., The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis Annals of the New York Academy of Sciences 2004 1012 252 266 (Pubitemid 38453530)
41. Chakrabarty A., Emerson M. R., LeVine S. M., Heme oxygenase-I in SJL mice with experimental allergic encephalomyelitis Multiple Sclerosis 2003 9 4 372 381 (Pubitemid 36958020)
42. LeVine S. M., Lynch S. G., Ou C. -N., Wulser M. J., Tam E., Boo N., Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients Brain Research 1999 821 2 511 515 (Pubitemid 29222815)
43. Sfagos C., Makis A. C., Chaidos A., Hatzimichael E. C., Dalamaga A., Kosma K., Bourantas K. L., Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients Multiple Sclerosis 2005 11 3 272 275 (Pubitemid 40775181)
44. Sayre L. M., Zelasko D. A., Harris P. L. R., Perry G., Salomon R. G., Smith M. A., 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease Journal of Neurochemistry 1997 68 5 2092 2097 (Pubitemid 27176147)
45. Smith M. A., Tabaton M., Perry G., Early contribution of oxidative glycation in Alzheimer disease [2] Neuroscience Letters 1996 217 2-3 210 211 (Pubitemid 26358841)
46. Smith M. A., Harris P. L. R., Sayre L. M., Perry G., Iron accumulation in Alzheimer disease is a source of redox-generated free radicals Proceedings of the National Academy of Sciences of the United States of America 1997 94 18 9866 9868 (Pubitemid 27408156)
47. Hegde M. L., Hegde P. M., Holthauzen L. M.F., Hazra T. K., Rao K. S.J., Mitra S., Specific inhibition of NEIL-initiated repair of oxidized base damage in human genome by copper and iron: potential etiological linkage to neurodegenerative diseases Journal of Biological Chemistry 2010 285 37 28812 28825
48. Lovell M. A., Robertson J. D., Teesdale W. J., Campbell J. L., Markesbery W. R., Copper, iron and zinc in Alzheimer's disease senile plaques Journal of the Neurological Sciences 1998 158 1 47 52 (Pubitemid 28277534)
49. Falangola M. F., Lee S. -P., Nixon R. A., Duff K., Helpern J. A., Histological co-localization of iron in A plaques of PS/APP transgenic mice Neurochemical Research 2005 30 2 201 205 (Pubitemid 40569203)
50. Cherny R. A., Legg J. T., McLean C. A., Fairlie D. P., Huang X., Atwood C. S., Beyreuther K., Tanzi R. E., Masters C. L., Bush A. I., Aqueous dissolution of Alzheimer's disease A amyloid deposits by biometal depletion Journal of Biological Chemistry 1999 274 33 23223 23228
51. Butterfield D. A., Bader Lange M. L., Sultana R., Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease Biochimica et Biophysica Acta 2010 1801 8 924 929
52. Smith M. A., Zhu X., Tabaton M., Liu G., McKeel Jr. D. W., Cohen M. L., Wang X., Siedlak S. L., Dwyer B. E., Hayashi T., Nakamura M., Nunomura A., Perry G., Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment Journal of Alzheimer's Disease 2010 19 1 363 372
53. Zhu W. -Z., Zhong W. -D., Wang W., Zhan C. -J., Wang C. -Y., Qi J. -P., Wang J. -Z., Lei T., Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease Radiology 2009 253 2 497 504
54. Sullivan E. V., Adalsteinsson E., Rohlfing T., Pfefferbaum A., Relevance of iron deposition in deep gray matter brain structures to cognitive and motor performance in healthy elderly men and women: exploratory findings Brain Imaging and Behavior 2009 3 2 167 175
55. Collingwood J. F., Mikhaylova A., Davidson M., Batich C., Streit W. J., Terry J., Dobson J., In situ characterization and mapping of iron compounds in Alzheimer's disease tissue Journal of Alzheimer's Disease 2005 7 4 267 272 (Pubitemid 41206937)
56. Bartzokis G., Tishler T. A., Shin IL. S., Lu PO. H., Cummings J. L., Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases Annals of the New York Academy of Sciences 2004 1012 224 236 (Pubitemid 38453528)
57. Cass W. A., Grondin R., Andersen A. H., Zhang Z., Hardy P. A., Hussey-Andersen L. K., Rayens W. S., Gerhardt G. A., Gash D. M., Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys Neurobiology of Aging 2007 28 2 258 271 (Pubitemid 44894635)
58. Connor J. R., Snyder B. S., Beard J. L., Fine R. E., Mufson E. J., Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease Journal of Neuroscience Research 1992 31 2 327 335
59. Martin W. R. W., Ye F. Q., Allen P. S., Increasing striatal iron content associated with normal aging Movement Disorders 1998 13 2 281 286 (Pubitemid 28127804)
60. Casadesus G., Smith M. A., Zhu X., Aliev G., Cash A. D., Honda K., Petersen R. B., Perry G., Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species Journal of Alzheimer's Disease 2004 6 2 165 169 (Pubitemid 38560252)
61. Kaur D., Andersen J., Does cellular iron dysregulation play a causative role in Parkinson's disease? Ageing Research Reviews 2004 3 3 327 343 (Pubitemid 38844698)
62. Ke YA., Qian Z. M., Iron misregulation in the brain: a primary cause of neurodegenerative disorders Lancet Neurology 2003 2 4 246 253 (Pubitemid 37443312)
63. Thomas M., Jankovic J., Neurodegenerative disease and iron storage in the brain Current Opinion in Neurology 2004 17 4 437 442 (Pubitemid 39071420)
64. Bartzokis G., Lu P. H., Tishler T. A., Peters D. G., Kosenko A., Barrall K. A., Finn J. P., Villablanca P., Laub G., Altshuler L. L., Geschwind D. H., Mintz J., Neely E., Connor J. R., Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men Journal of Alzheimer's Disease 2010 20 1 333 341
65. Dornelles A. S., Garcia V. A., De Lima M. N. M., Vedana G., Alcalde L. A., Bogo M. R., Schrder N., mRNA expression of proteins involved in iron homeostasis in brain regions is altered by age and by iron overloading in the neonatal period Neurochemical Research 2010 35 4 564 571
66. Xu X., Wang Q., Zhang M., Age, gender, and hemispheric differences in iron deposition in the human brain: an in vivo MRI study NeuroImage 2008 40 1 35 42
67. Morita T., Mizutani Y., Sawada M., Shimada A., Immunohistochemical and ultrastructural findings related to the blood-brain barrier in the blood vessels of the cerebral white matter in aged dogs Journal of Comparative Pathology 2005 133 1 14 22 (Pubitemid 40744453)
68. Aguirre P., Mena N., Tapia V., Arredondo M., Nez M. T., Iron homeostasis in neuronal cells: a role for IREG1 BMC Neuroscience 2005 6, article 3
69. Shi Z. -H., Nie G., Duan X. -L., Rouault T., Wu W. -S., Ning B., Zhang N., Chang Y. -Z., Zhao B. -L., Neuroprotective mechanism of mitochondrial ferritin on 6-hydroxydopamine- induced dopaminergic cell damage: implication for neuroprotection in Parkinson's disease Antioxidants and Redox Signaling 2010 13 6 783 796
70. Salazar J., Mena N., Hunot S., Prigent A., Alvarez-Fischer D., Arredondo M., Duyckaerts C., Sazdovitch V., Zhao L., Garrick L. M., Nuez M. T., Garrick M. D., Raisman-Vozari R., Hirsch E. C., Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America 2008 105 47 18578 18583
71. Puccio H., Simon D., Cosse M., Criqui-Filipe P., Tiziano F., Melki J., Hindelang C., Matyas R., Rustin P., Koenig M., Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits Nature Genetics 2001 27 2 181 186 (Pubitemid 32157445)
72. Kakhlon OR., Breuer W., Munnich A., Cabantchik Z. I., Iron redistribution as a therapeutic strategy for treating diseases of localized iron accumulation Canadian Journal of Physiology and Pharmacology 2010 88 3 187 196
73. Zhang L., Zhao B., Yew D. T., Kusiak J. W., Roth G. S., Processing of Alzheimer's amyloid precursor protein during HO-induced apoptosis in human neuronal cells Biochemical and Biophysical Research Communications 1997 235 3 845 848 (Pubitemid 27326572)
74. Atwood C. S., Moir R. D., Huang X., Scarpa R. C., Bacarra N. M. E., Romano D. M., Hartshorn M. A., Tanzi R. E., Bush A. I., Dramatic aggregation of alzheimer by Cu(II) is induced by conditions representing physiological acidosis Journal of Biological Chemistry 1998 273 21 12817 12826 (Pubitemid 28246837)
75. Atwood C. S., Scarpa R. C., Huang X., Moir R. D., Jones W. D., Fairlie D. P., Tanzi R. E., Bush A. I., Characterization of copper interactions with Alzheimer amyloid peptides: identification of an attomolar-affinity copper binding site on amyloid 1-42 Journal of Neurochemistry 2000 75 3 1219 1233 (Pubitemid 30660512)
76. Rottkamp C. A., Atwood C. S., Joseph J. A., Nunomura A., Perry G., Smith M. A., The state versus amyloid- : the trial of the most wanted criminal in Alzheimer disease Peptides 2002 23 7 1333 1341 (Pubitemid 34786712)
77. Sayre L. M., Perry G., Harris P. L. R., Liu Y., Schubert K. A., Smith M. A., In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals Journal of Neurochemistry 2000 74 1 270 279 (Pubitemid 30012778)
78. Atwood C. S., Obrenovich M. E., Liu T., Chan H., Perry G., Smith M. A., Martins R. N., Amyloid- : a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid- Brain Research Reviews 2003 43 1 1 16 (Pubitemid 37130077)
79. Ritchie C. W., Bush A. I., Mackinnon A., Macfarlane S., Mastwyk M., MacGregor L., Kiers L., Cherny R., Li Q. X., Tammer A., Carrington D., Mavros C., Volitakis I., Xilinas M., Ames D., Davis S., Beyreuther K., Tanzi R. E., Masters C. L., Metal-protein attenuation with Iodochlorhydroxyquin (Clioquinol) targeting A amyloid deposition and toxicity in alzheimer disease: a pilot phase 2 clinical trial Archives of Neurology 2003 60 12 1685 1691 (Pubitemid 37521621)
80. Perez C. A., Tong Y., Guo M., Iron chelators as potential therapeutic agents for Parkinson's disease Current Bioactive Compounds 2008 4 3 150 158
81. Cherny R. A., Barnham K. J., Lynch T., Volitakis I., Li Q. X., McLean C. A., Multhaup G., Beyreuther K., Tanzi R. E., Masters C. L., Bush A. I., Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease Journal of Structural Biology 2000 130 2-3 209 216
82. Cherny R. A., Atwood C. S., Xilinas M. E., Gray D. N., Jones W. D., McLean C. A., Barnham K. J., Volitakis I., Fraser F. W., Kim Y. S., Huang X., Goldstein L. E., Moir R. D., Lim J. T., Beyreuther K., Zheng H., Tanzi R. E., Masters C. L., Bush A. I., Treatment with a copper-zinc chelator markedly and rapidly inhibits -amyloid accumulation in Alzheimer's disease transgenic mice Neuron 2001 30 3 665 676 (Pubitemid 32607332)
83. Regland B., Lehmann W., Abedini I., Blennow K., Jonsson M., Karlsson I., Sjgren M., Wallin A., Xilinas M., Gottfries C. G., Treatment of Alzheimer's disease with clioquinol Dementia and Geriatric Cognitive Disorders 2001 12 6 408 414 (Pubitemid 34701665)
84. Nunomura A., Moreira P. I., Lee H. G., Zhu X., Castellani R. J., Smith M. A., Perry G., Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases CNS and Neurological DisordersDrug Targets 2007 6 6 411 423 (Pubitemid 351486255)
85. Petersen R. B., Nunomura A., Lee H. G., Casadesus G., Perry G., Smith M. A., Zhu X., Signal transduction cascades associated with oxidative stress in Alzheimer's disease Journal of Alzheimer's Disease 2007 11 2 143 152 (Pubitemid 47010981)
86. Salvador G. A., Iron in neuronal function and dysfunction BioFactors 2010 36 2 103 110
87. Guo Z. H., Mattson M. P., Neurotrophic factors protect cortical synaptic terminals against amyloid- and oxidative stress-induced impairment of glucose transport, glutamate transport and mitochondrial function Cerebral Cortex 2000 10 1 50 57 (Pubitemid 30022832)
88. Uranga R. M., Mateos M. V., Giusto N. M., Salvador G. A., Activation of phosphoinositide-3 kinase/Akt pathway by FeSO 4 in rat cerebral cortex synaptic endings Journal of Neuroscience Research 2007 85 13 2924 2932 (Pubitemid 47523577)
89. Uranga R. M., Giusto N. M., Salvador G. A., Iron-induced oxidative injury differentially regulates PI3K/Akt/ GSK3 pathway in synaptic endings from adult and aged rats Toxicological Sciences 2009 111 2 331 344
90. Mattson M. P., Apoptotic and anti-apoptotic synaptic signaling mechanisms Brain Pathology 2000 10 2 300 312 (Pubitemid 30181099)
91. DeKosky S. T., Scheff S. W., Styren S. D., Structural correlates of cognition in dementia: quantification and assessment of synapse change Neurodegeneration 1996 5 4 417 421 (Pubitemid 27077903)
92. Kuperstein F., Yavin E., Pro-apoptotic signaling in neuronal cells following iron and amyloid beta peptide neurotoxicity Journal of Neurochemistry 2003 86 1 114 125 (Pubitemid 36753852)
93. Kuperstein F., Brand A., Yavin E., Amyloid A preconditions non-apoptotic signals in vivo and protects fetal rat brain from intrauterine ischemic stress Journal of Neurochemistry 2004 91 4 965 974 (Pubitemid 39507373)
94. Mattson M. P., NF- B in the survival and plasticity of neurons Neurochemical Research 2005 30 6-7 883 893
95. Uranga R. M., Giusto N. M., Salvador G. A., Effect of transition metals in synaptic damage induced by amyloid beta peptide Neuroscience 2010 170 2 381 389
96. Choi S. H., Kim Y. W., Kim S. G., AMPK-mediated GSK3 inhibition by isoliquiritigenin contributes to protecting mitochondria against iron-catalyzed oxidative stress Biochemical Pharmacology 2010 79 9 1352 1362
97. Rockenstein E., Torrance M., Adame A., Mante M., Bar-on P., Rose J. B., Crews L., Masliah E., Neuroprotective effects of regulators of the glycogen synthase kinase-3 signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation Journal of Neuroscience 2007 27 8 1981 1991
98. Hidalgo C., Nez M. T., Calcium, iron and neuronal function IUBMB Life 2007 59 4-5 280 285 (Pubitemid 46763780)
99. Adamo A. M., Oteiza P. I., Zinc deficiency and neurodevelopment: the case of neurons BioFactors 2010 36 2 117 124
100. Mattson M. P., Culmsee C., Yu Z., Camandola S., Roles of nuclear factor B in neuronal survival and plasticity Journal of Neurochemistry 2000 74 2 443 456 (Pubitemid 30053716)
101. Toyoda T., Kassell N. F., Lee K. S., Induction of ischemic tolerance and antioxidant activity by brief focal ischemia NeuroReport 1997 8 4 847 851 (Pubitemid 27152132)
102. Glazner G. W., Camandola S., Mattson M. P., Nuclear factor- B mediates the cell survival-promoting action of activity-dependent neurotrophic factor peptide-9 Journal of Neurochemistry 2000 75 1 101 108 (Pubitemid 30418174)
103. Terai K., Matsuo A., McGeer P. L., Enhancement of immunoreactivity for NF- B in the hippocampal formation and cerebral cortex of Alzheimer's disease Brain Research 1996 735 1 159 168 (Pubitemid 26336632)
104. Bourne K. Z., Ferrari D. C., Lange-Dohna C., Roner S., Wood T. G., Perez-Polo J. R., Differential regulation of BACE1 promoter activity by nuclear factor- B in neurons and glia upon exposure to -amyloid peptides Journal of Neuroscience Research 2007 85 6 1194 1204 (Pubitemid 46724363)
105. Boissire F., Hunot S., Faucheux B., Duyckaerts C., Hauw J. J., Agid Y., Hirsch E. C., Nuclear translocation of NF- B in cholinergic neurons of patients with Alzheimer's disease NeuroReport 1997 8 13 2849 2852 (Pubitemid 27394805)
106. Lukiw W. J., Bazan N. G., Strong nuclear factor- B-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex Journal of Neuroscience Research 1998 53 5 583 592 (Pubitemid 28380799)
107. Kaltschmidt B., Uherek M., Wellmann H., Volk B., Kaltschmidt C., Inhibition of NF- B potentiates amyloid -mediated neuronal apoptosis Proceedings of the National Academy of Sciences of the United States of America 1999 96 16 9409 9414 (Pubitemid 29374768)
108. Lee D. W., Andersen J. K., Role of HIF-1 in iron regulation: potential therapeutic strategy for neurodegenerative disorders Current Molecular Medicine 2006 6 8 883 893 (Pubitemid 44883938)
109. Martin F., Linden T., Katschinski D. M., Oehme F., Flamme I., Mukhopadhyay C. K., Eckhardt K., Trger J., Barth S., Camenisch G., Wenger R. H., Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation Blood 2005 105 12 4613 4619 (Pubitemid 40807279)
110. Tacchini L., Gammella E., De Ponti C., Recalcati S., Cairo G., Role of HIF-1 and NF- B transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals Journal of Biological Chemistry 2008 283 30 20674 20686
111. Wang D., Wang L. -H., Zhao Y., Lu Y. -P., Zhu L., Hypoxia regulates the ferrous iron uptake and reactive oxygen species level via divalent metal transporter 1 (DMT1) exon1B by hypoxia-inducible factor-1 IUBMB Life 2010 62 8 629 636
112. Avramovich-Tirosh Y., Bar-Am O., Amit T., Youdim M. B.H., Weinreb O., Up-regulation of hypoxia-inducible factor (hif)-1 and hif-target genes in cortical neurons by the novel multifunctional iron chelator anti-alzheimer drug, M30 Current Alzheimer Research 2010 7 4 300 306
113. Scortegagna M., Galdzicki Z., Rapoport S. I., Hanbauer I., Activator protein-1 DNA binding activation by hydrogen peroxide in neuronal and astrocytic primary cultures of trisomy-16 and diploid mice Molecular Brain Research 1999 73 1-2 144 150
114. Aimo L., Oteiza P. I., Zinc deficiency increases the susceptibility of human neuroblastoma cells to lead-induced activator protein-1 activation Toxicological Sciences 2006 91 1 184 191
115. Toone W. M., Morgan B. A., Jones N., Redox control of AP-1-like factors in yeast and beyond Oncogene 2001 20 19 2336 2346 (Pubitemid 32531293)
116. Benvenisti-Zarom L., Chen-Roetling J., Regan R. F., Inhibition of the ERK/MAP kinase pathway attenuates heme oxygenase-1 expression and heme-mediated neuronal injury Neuroscience Letters 2006 398 3 230 234 (Pubitemid 44274990)
117. Huang E., Ong W. -Y., Go M. -L., Connor J. R., Upregulation of iron regulatory proteins and divalent metal transporter-1 isoforms in the rat hippocampus after kainate induced neuronal injury Experimental Brain Research 2006 170 3 376 386
118. Lee K. S., Iijima-Ando K., Iijima K., Lee W. J., Lee J. H., Yu K., Lee D. S., JNK/FOXO-mediated neuronal expression of fly homologue of peroxiredoxin II reduces oxidative stress and extends life span Journal of Biological Chemistry 2009 284 43 29454 29461
119. Lehtinen M. K., Yuan Z., Boag P. R., Yang Y., Villn J., Becker E. B. E., DiBacco S., de la Iglesia N., Gygi S., Blackwell T. K., Bonni A., A Conserved MST-FOXO Signaling Pathway Mediates Oxidative-Stress Responses and Extends Life Span Cell 2006 125 5 987 1001 (Pubitemid 43795191)
120. Yuan Z., Lehtinen M. K., Merlo P., Villn J., Gygi S., Bonni A., Regulation of neuronal cell death by MST1-FOXO1 signaling Journal of Biological Chemistry 2009 284 17 11285 11292